Skip to main content

Vivaldi Capital Management LP

Position in GALT — Galectin Therapeutics Inc

CIK 1682021 CHICAGO, IL

Position in GALT

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$721,449
-$127,482 QoQ
Shares Held
258,584
+26.7% QoQ
Ownership
0.256%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GALT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Vivaldi Capital Management LP holds $3,172,478 across 4 Biotechnology names. GALT ranks #2 (22.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 GALT
Galectin Therapeutics Inc
This page
258,584 $721,449

All Filings in GALT

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $721,449 258,584
2025-12-31 $848,931 204,070
2025-09-30 $1,084,388 255,752
2025-06-30 $363,854 172,443
2025-03-31 $67,866 55,628
2024-12-31 $58,860 45,628
2024-09-30 $66,088 24,032
2024-06-30 $54,312 24,032
2024-03-31 $57,436 24,032
2023-12-31 $31,973 19,261
2023-09-30 $36,981 19,261
2023-06-30 $27,735 19,261
2023-03-31 $40,448 19,261
2022-12-31 $21,764 19,261
2022-09-30 $31,395 19,261
2022-06-30 $22,372 17,078
2022-03-31 $27,495 17,078
2021-12-31 $22,082 10,668
2021-09-30 $41,391 10,668
2021-06-30 $34,137 10,668
2021-03-31 $23,149 10,668
2020-12-31 $34,583 15,439
2020-09-30 $41,222 15,439
2020-06-30 $47,243 15,439
2020-03-31 $20,909 10,668